Gw Pharmaceuticals Plc Stock Current Ratio
GW Pharmaceuticals Plc fundamentals help investors to digest information that contributes to GW Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of GWPH Stock. The fundamental analysis module provides a way to measure GW Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GW Pharmaceuticals stock.
GWPH |
GWPH Current Ratio Analysis
GW Pharmaceuticals' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current GW Pharmaceuticals Current Ratio | 4.57 X |
Most of GW Pharmaceuticals' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GW Pharmaceuticals Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, GW Pharmaceuticals Plc has a Current Ratio of 4.57 times. This is 57.04% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current ratio for all United States stocks is 111.57% lower than that of the firm.
GWPH Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GW Pharmaceuticals' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GW Pharmaceuticals could also be used in its relative valuation, which is a method of valuing GW Pharmaceuticals by comparing valuation metrics of similar companies.GW Pharmaceuticals is currently under evaluation in current ratio category among related companies.
GWPH Fundamentals
Return On Equity | -7.92 | |||
Return On Asset | -3.55 | |||
Profit Margin | (11.03) % | |||
Operating Margin | (9.82) % | |||
Current Valuation | 6.42 B | |||
Shares Outstanding | 31.54 M | |||
Shares Owned By Insiders | 0.20 % | |||
Shares Owned By Institutions | 80.35 % | |||
Number Of Shares Shorted | 693.73 K | |||
Price To Earning | 126.70 X | |||
Price To Book | 9.24 X | |||
Price To Sales | 12.92 X | |||
Revenue | 527.2 M | |||
Gross Profit | 489.67 M | |||
EBITDA | (39.01 M) | |||
Net Income | (58.13 M) | |||
Cash And Equivalents | 486.75 M | |||
Cash Per Share | 15.53 X | |||
Total Debt | 43.64 M | |||
Debt To Equity | 0.06 % | |||
Current Ratio | 4.57 X | |||
Book Value Per Share | 23.70 X | |||
Cash Flow From Operations | (27.39 M) | |||
Short Ratio | 1.15 X | |||
Earnings Per Share | (1.86) X | |||
Price To Earnings To Growth | 3.61 X | |||
Number Of Employees | 1.16 K | |||
Beta | 1.67 | |||
Market Capitalization | 6.81 B | |||
Total Asset | 453.18 M | |||
Retained Earnings | (813.7 M) | |||
Working Capital | 369.57 M | |||
Current Asset | 404.52 M | |||
Current Liabilities | 34.95 M | |||
Z Score | 93.2 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in GWPH Stock
If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |